Dr. John David Scandling, MD
- Medicare services, 2022
- 163
- Part D claims, 2022
- 37
- Publications
- 53
- Clinical trials
- 4
- Hospital affiliations
- 2
- Practice address
- 300 Pasteur Drive, Stanford, CA 94305
- Practice phone
- Call (650) 723-4000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Scandling's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. John David Scandling is a nephrologist in Stanford, California
Dr. Scandling practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.
Dr. Scandling's NPI, 1174665020, was assigned on February 13, 2007. Dr. Scandling graduated from VCU School of Medicine in 1978. Dr. Scandling holds California license G66051.
- NPI
- 1174665020NPI Registry (opens in a new tab)
- NPI enumeration date
- February 13, 2007
- NPI status
- Active
- Practice phone
- (650) 723-4000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 74
- Medical school graduation
- 1978
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. John David Scandling practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California
Dr. Scandling's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.
- Stanford Hospital at 300 Pasteur Drive300 Pasteur Drive, Stanford, CA 94305 · Santa Clara CountyPhone(650) 723-4000
Source: Dmand AI Affiliation Data
Dr. John David Scandling is affiliated with 2 sites of care and 2 medical groups
Dr. Scandling's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Scandling to 1 more hospital and 1 medical group, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. John David Scandling's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Scandling practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Stanford Hospital at 300 Pasteur Drive | Available with a free account |
| +1 more site and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Stanford University and 6.2K+ hospitals, with verified contacts in the same login.
Dr. John David Scandling is one of 1,401 nephrologists in California
Nephrology is Dr. Scandling's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Scandling is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Scandling's licenses on file in 5 states: California, Nevada, Virginia, New York and West Virginia.
Specialties and state licenses
- Nephrology, CaliforniaPrimary
- Nevada license
- Virginia license
- New York license
- West Virginia license
Nephrologists near Dr. Scandling
Counts of nephrologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. John David Scandling billed Medicare for 163 services in 2022
CMS data shows 163 Medicare services from Dr. Scandling across 3 procedure codes in 2022. Medicare paid $10,657 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Scandling's Medicare services by type, 2021 to 2022
- 2021
- 2022
- Office and hospital visits
- 2021: 302022: 97223%
- Tests and treatments
- 2021: 02022: 66
Dr. Scandling compared with the California median for nephrologists, 2022
- Dr. Scandling
- California median
- Medicare services
- 163vs 1,08485% below
- Part D claims
- 37vs 95596% below
Medians across 1,355 nephrologists in California with Dmand AI profiles that report each measure.
Dr. Scandling's most billed Medicare procedure codes, 2022
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Scandling?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Scandling and other nephrologists in California.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. John David Scandling's patients have a median age of 63
Across all payers, Dmand AI patient panel data puts Dr. Scandling's median patient age at 63, with 40% women.
Dr. Scandling's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 63
Patient panel by sex, all payers
- Women40%
- Men60%
Source: Dmand AI Patient Panel Data
Dr. John David Scandling wrote 37 Medicare Part D claims in 2022
In 2022, Dr. Scandling wrote 37 Medicare Part D claims. Every claim was for a generic drug. They cover 3 drugs, with $210 in total drug cost. In 2021, CMS named 13 claims across 1 drug.
Dr. Scandling's most prescribed drugs by claims, 2022
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2021 to 2022
- 2021
- 2022
- Claims for drugs CMS names
- 2021: 132022: 37185%
Drugs named by CMS: 3 in 2022, 1 in 2021.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. John David Scandling has 53 publications on record
Dmand AI links 53 papers to Dr. Scandling, published from 2005 to 2025. 2014 was the busiest year, with 3. The most frequent topics are Kidney Transplantation, Immunosuppressive Agents and Graft Survival. Dr. Scandling has published most often in Transplantation. Dr. Scandling's most frequent co-authors are Stephan Busque, MD, Robert Lowsky, MD and Glenn Matthew Chertow, MD.
Dr. Scandling's papers by year, 2012 to 2025
Topics Dr. Scandling writes about most
- Kidney Transplantation
- Immunosuppressive Agents
- Graft Survival
- Kidney Failure, Chronic
- Hematopoietic Stem Cell Transplantation
- Kidney
- Glomerular Filtration Rate
- Graft Rejection
Dr. Scandling's most frequent co-authors
- Stephan Busque, MD16 shared papers
- Robert Lowsky, MD9 shared papers
- Glenn Matthew Chertow, MD6 shared papers
Recent publications by Dr. Scandling
See who Dr. Scandling researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Scandling works with, so you can find a warm path to the right nephrologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. John David Scandling has worked on 4 clinical trials
Dmand AI links Dr. Scandling to 4 clinical trials. 2 are still active or recruiting. Conditions studied include Diabetic Nephropathies, Kidney Failure, Chronic and Diabetes Complications. Stanford University sponsors the most, 2. Open Payments lists research payments to Dr. Scandling that name 1 trial.
Clinical trials with Dr. Scandling by phase
- 1Phase 1: 1 trial
- 1Phase 1/2: 1 trial
- NonePhase 2: no trials
- NonePhase 3: no trials
- 1Phase 4: 1 trial
Conditions in Dr. Scandling's trials
- Diabetic Nephropathies
- Kidney Failure, Chronic
- Diabetes Complications
- Renal Insufficiency, Chronic
Investigators on the most trials with Dr. Scandling
Recent clinical trials with Dr. Scandling
Combined Blood Stem Cell and Kidney Transplant of One Haplotype Match Living Donor Pairs. (opens in a new tab)
Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM) (opens in a new tab)
Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. John David Scandling received $3,054 in industry payments from 2016 to 2022
CMS Open Payments shows 7 general payments to Dr. Scandling from 3 drug and device companies from 2016 to 2022. Consulting fees make up the largest share, 85% of the total. Mallinckrodt Enterprises LLC paid the most, $2,166. It also lists 1 research payment totaling $5,175 in 2025, naming 1 clinical trial.
General payments to Dr. Scandling by program year, 2016 to 2022
General payments to Dr. Scandling by kind, 2016 to 2022
- Consulting fees$2,60085%
- Food and beverage$44415%
- Education$100%
Companies that paid Dr. Scandling the most, 2016 to 2022
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. John David Scandling has 1 award and honors on record
Dmand AI lists 1 award for Dr. Scandling, most recently CMS Stage 1 EHR in 2013.
Awards and honors for Dr. Scandling
- 2013
- CMS Stage 1 EHR
Source: Dmand AI Professional Profile Data
Dr. John David Scandling graduated from VCU School of Medicine
Dr. Scandling graduated from VCU School of Medicine in 1978.
- Medical school
- Board certified in internal medicine
- Board certified in nephrology
Source: Dmand AI Professional Profile Data
Dr. John David Scandling accepts plans from 8 insurance carriers
Dr. Scandling is in network with 8 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.
- Aetna
- Elevance
- United Healthcare
- Blue Cross Blue Shield of Michigan
- HCSC
- Blue Cross Blue Shield of Massachusetts
- Blue Cross and Blue Shield of Kansas City
- NV State Medicaid
Plan types Dr. Scandling accepts, by number of carriers
- PPO6
- HMO5
- Medicare5
- POS4
- EPO3
- Medicaid1
Source: Dmand AI Insurance Network Data
Sources for Dr. John David Scandling's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. John David Scandling
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. John David Scandling's NPI number?
Dr. John David Scandling's NPI number is 1174665020. It was assigned on February 13, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. John David Scandling?
Dr. John David Scandling is a nephrologist in Stanford, California. The primary specialty in the NPI Registry is Nephrology Physician (taxonomy code 207RN0300X).
Where does Dr. John David Scandling practice?
Dr. Scandling practices at 300 Pasteur Drive, Stanford, CA 94305. Dr. Scandling's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dmand AI also links Dr. Scandling to 1 hospital and 1 medical group.
What is Dr. John David Scandling's office phone number?
The practice phone on file for Dr. Scandling is (650) 723-4000.
What is Dr. John David Scandling's medical license number?
Dr. Scandling holds California license G66051, one of the licenses on file in 5 states.
Which states has Dr. John David Scandling been licensed in?
Dmand AI has state licenses on file for Dr. Scandling in California (1989 to 2026), Nevada (2019 to 2025), Virginia (1984 to 2002), New York (1981 to 1997) and West Virginia (1979 to 1995).
Which hospitals is Dr. John David Scandling affiliated with?
Dr. Scandling practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California. Dmand AI links Dr. Scandling to 1 more hospital.
What medical group is Dr. John David Scandling part of?
Dr. Scandling is linked to Stanford Health Care. Dmand AI links Dr. Scandling to 1 more medical group.
Does Dr. John David Scandling accept Medicare?
Yes. CMS data shows Dr. Scandling billed Medicare for 163 services in 2022.
Is Dr. John David Scandling board certified?
Yes. Dr. Scandling is board certified in internal medicine by the American Board of Internal Medicine.
Show 8 more questionsShow fewer questions
What services does Dr. John David Scandling bill to Medicare?
In 2022, Dr. Scandling's most billed Medicare services were hospital inpatient care (99232), dialysis (90935) and office visit, established patient (99214).
Where did Dr. John David Scandling go to medical school?
Dr. Scandling graduated from VCU School of Medicine in 1978.
What drugs does Dr. John David Scandling prescribe most?
In 2022 Medicare Part D data, Dr. Scandling's most prescribed drugs by claims were Prednisone, Amlodipine Besylate and Metoprolol Tartrate.
Has Dr. John David Scandling received payments from drug or device companies?
CMS Open Payments shows $3,054 in general payments to Dr. Scandling from 3 companies from 2016 to 2022. The largest total came from Mallinckrodt Enterprises LLC.
How long has Dr. John David Scandling been practicing?
Dr. Scandling graduated from medical school in 1978, 48 years ago.
Does Dr. John David Scandling do research?
Dmand AI links 53 publications to Dr. Scandling, published from 2005 to 2025. Dr. Scandling has worked on 4 clinical trials.
Who does Dr. John David Scandling publish with?
Dr. Scandling's most frequent co-authors are Stephan Busque, MD (16 shared papers), Robert Lowsky, MD (9 shared papers) and Glenn Matthew Chertow, MD (6 shared papers).
What insurance does Dr. John David Scandling accept?
Dr. Scandling is in network with 8 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.
Selling to nephrology practices?
See nephrologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card